Peptide Library

Human study PLS-00165

Determination of thymosin beta4 and protein in human wound fluid after abdominal surgery.

Other design · Not reported participants enrolled · not included in the assessments (other)

Version 1 · published November 8, 2026 · evidence through November 8, 2026 · research snapshot 2026.1.1 · methodology ev-1 · Automated assessment by AI (claude-opus-5-5 and claude-sonnet-5-5), not reviewed by a person.

Only the abstract was available. Essential methods may be missing, which limits what can be judged.

Reports of this study

Every publication, registration and abstract describing this one study. Participants are counted once.

  • Determination of thymosin beta4 and protein in human wound fluid after abdominal surgery.primary · Annals of the New York Academy of Sciences · 2007-05-10 · PMID 17495244 · DOI

Design and participants

Design
Other design
Population
Patients after abdominal surgery whose wound fluid was collected by Robinson drainage; number and characteristics not stated
Conditions
Abdominal surgery, Surgical wound healing
Setting
Postoperative surgical setting; institution not stated
Planned enrollment (registry)
Not reported
Enrolled
Not reported
Randomized
Not reported
Completed follow-up
Not reported
Funding
Not stated
Authors’ conflicts
Not stated

Intervention and comparator

What each group received. Related peptides, analogs and combinations are never treated as the compound itself.

    What the authors reported

    As stated in the sources. This is the authors’ account, not Peptide Library’s assessment.

    Adverse events

    None reported. That is not evidence of safety.

    Monitoring: Not reported; no compound was administered

    The authors concluded (paraphrased): After abdominal surgery, total protein and endogenous thymosin beta4 levels in wound fluid fell over time. Neither thymosin beta10 nor oxidized thymosin beta4 was detected in the wound fluid.

    Peptide Library’s assessment

    An automated assessment, made by AI separately from the authors’ conclusions and not reviewed by a person. How risk of bias is assessed.

    Limitations

    • other: Endogenous Tβ4 was only measured and was never administered, so the study gives no information on treatment effects or safety.
    • abstract only: Only the abstract is available, and it does not report the number of patients or their characteristics.
    • no control group: Wound fluid was measured over time in surgical patients without any comparison group.
    • inappropriate population: No thymosin beta4 was given to participants. The study measured the endogenous peptide in surgical wound fluid, so it gives no intervention data.

    No risk-of-bias assessment has been published for this study’s results.

    Claims this study informs

    Where each value comes from

    • author_conclusion: PMID 17495244, abstract (sentences 4-6) · extracted by AI (automated, not verified by a person) · abstract only
    • design: PMID 17495244, abstract (sentences 1-3) · extracted by AI (automated, not verified by a person) · abstract only
    • limitations: PMID 17495244, abstract (sentences 1-6) · extracted by AI (automated, not verified by a person) · abstract only
    • population: PMID 17495244, abstract (sentences 1-2) · extracted by AI (automated, not verified by a person) · abstract only

    • Version 1 · published November 8, 2026 · evidence through November 8, 2026 · research snapshot 2026.1.1 · methodology ev-1 · Automated assessment by AI (claude-opus-5-5 and claude-sonnet-5-5), not reviewed by a person.

    These assessments describe published research. Records marked automated were produced by AI under the published methodology and have not been reviewed by a person; they can contain errors. None of this is medical advice, not a statement about any product’s safety for human use, and not a regulatory approval. Peptide Library’s vendor and partner relationships play no part in them (editorial independence).